Biotech Series C Investors & VC Firms
430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.
Kolon Investment, Inc.
SeoulSeed–Late Stage
Quam Venture Capital
LondonPre-Seed–Growth$500K – $10M
6 people
InVivium Capital
ChicagoSeed–Growth
6 people
TPB
San FranciscoSeed–Late Stage
6 people
Vision Creator
SeoulSeed–Late Stage
BSK Investment
SeoulSeed–Late Stage
14 people
Axil Capital
TokyoSeed–Late Stage
7 people
ACORN BIOVENTURES
New YorkSeed–Late Stage
3 people
Interface Fund
San FranciscoSeed–Growth$1M – $10M
2 people
NJF Capital
LondonSeed–Growth
2 people
Gore Range Capital
SouthlakeSeries A–Late Stage$500K – $5M
3 people
PBM Capital
CharlottesvilleSeries A–Late Stage
6 people
Percipient Capital
LondonSeed–Late Stage$1.3M – $6.3M
3 people
BioFrontier Partners, Inc.
TokyoSeries A–Late Stage$500K – $3M
11 people
Mizuho Capital
TokyoPre-Seed–Growth
1 person
INP Capital
VancouverSeed–Late Stage
6 people
Alium Capital
SydneySeed–Late Stage
5 people
Roadmap Capital Inc.
TorontoSeed–Late Stage
5 people
AddVentures by SCG
BangkokSeed–Growth
6 people
Muirwoods Ventures
SeoulSeed–Late Stage
MPCi (formerly Matrix Partners China)
BeijingPre-Seed–Series B
13 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
4 people
dsm-firmenich Venturing
MaastrichtSeed–Growth$108K – $5.4M
9 people
Anais Ventures
LancySeries A–Series C
3 people
Related lists
Biotech Investors & VC Firms (2504)Biotech Seed Investors & VC Firms (2043)Series C Investors & VC Firms (1709)Biotech Series A Investors & VC Firms (1638)Biotech Investors & VC Firms in North America (1618)Biotech Investors & VC Firms in United States (1466)Biotech Investors & VC Firms in Europe (961)Series C Investors & VC Firms in North America (942)Biotech Pre-Seed Investors & VC Firms (931)Biotech Investors & VC Firms in Global (826)
Data sourced from public filings and firms' own websites — see our methodology.




























































